Imaging of benign and malignant focal liver lesions: MR versus CT

Magnetic Resonance Imaging Clinics of North America

Volumn 9, Issue 4, 2001, Pages 785-802

  Martin, D R ^a   Semelka, R C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; INTERMETHOD COMPARISON; LIVER CANCER; LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; GADOLINIUM; HUMANS; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0034765817     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (86)

1. Differential diagnosis of hepatic neoplasms: Spin echo versus gadolinium-diethylenetriaminepentaacetate-enhanced gradient echo imaging
2. Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide (SHU-555-A)
3. Hepatic adenomatosis
4. Acute and subacute liver-related hemorrhage: MRI findings
5. Contrast nephrotoxicity
6. Detection of focal hepatic lesions: Comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP
7. Focal nodular hyperplasia of the liver
8. Hepatic adenoma and focal nodular hyperplasia: MR findings with superparamagnetic iron oxide-enhanced MRI
9. Differentiation between multiple liver hemangiomas and liver metastases of gastrinomas: Value of enhanced MRI
10. MR imaging of adrenal masses: Value of chemical-shift imaging for distinguishing adenomas from other tumors
11. Comparison of contrast enhanced CT and Mn-DPDP enhanced MRI for detection of focal hepatic lesions. Initial findings
12. Optimizing lesion contrast without using contrast agents
13. From the Archives of the AFIP. Mucinous cystic neoplasms of the pancreas: Radiologic-pathologic correlation
14. Gadolinium-DTPA as a contrast agent in MRI: Initial clinical experience in 20 patients
15. Calcification in focal nodular hyperplasia: A new problem for differentiation from fibrolamellar hepatocellular carcinoma
16. Imaging of nontraumatic hemorrhagic hepatic lesions
17. Unusual appearance of focal nodular hyperplasia with fatty change
18. Ultrafast imaging using gradient echoes
19. Dysplastic nodules of the liver: Imaging findings
20. Determination of serum creatinine prior to iodinated contrast media: Is it necessary in all patients?
21. Hepatic T2-weighted MRI: A prospective comparison of sequences, including breath-hold, half-Fourier turbo spin echo (HASTE)
22. Multiple focal nodular hyperplasia
23. Hepatic adenoma and focal nodular hyperplasia: Diagnosis and criteria for treatment
24. Contrast-enhanced hepatic MRI: Comparison of half-dose and standard-dose gadolinium DTPA administration in lesion characterization with T1-weighted gradient echo sequences
25. Hepatic focal nodular hyperplasia: New MR findings
26. Advances in abdominal MR imaging
27. Multiphase hepatic CT with a multirow detector CT scanner
28. Detection of hepatic metastases: Comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging
29. Case report: Haemorrhagic hepatic adenoma-MR features
30. Liver adenomatosis: Clinical, histopathologic, and imaging findings in 15 patients
31. Fatal adverse event secondary to high osmolality contrast agent
32. Effects of biphasic spiral CT conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions
33. T2-weighted breathold imaging of the liver: A quantitative and qualitative comparison of fast spin echo and half Fourier single shot fast spin echo imaging
34. CT and MR imaging of benign hepatic and biliary tumors
35. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: Correlation with histological grading
36. Malignant lesions of the liver with high signal intensity on T1-weighted MR images
37. Hepatocellular carcinoma in North America: A multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images
38. Inflammatory pseudotumor of the liver: Appearance on contrast enhanced helical CT and dynamic MR images
39. Liver MR imaging: Comparison of respiratory triggered fast spin echo with T2-weighted spin-echo and inversion recovery
40. Siderotic nodules at MR imaging: Regenerative or dysplastic?
41. Current uses of gadolinium chelates for clinical magnetic resonance imaging examination of the liver
42. Atypical hepatic hemangiomas with intense arterial enhancement and early fading
43. Sequential use of gadolinium chelate and mangafodipir trisodium for the assessment of focal liver lesions: Initial observations
44. Benign lesions of the liver
45. Hepatic imaging: Techniques and unique applications of magnetic resonance imaging
46. CT and MR imaging findings in focal nodular hyperplasia of the liver: Radiologic-pathologic correlation
47. SPIO-MR imaging versus double-phase spiral CT in detecting malignant lesions of the liver
48. Differentiation between hepatoma and hemangioma with inversion-recovery snapshot FLASH MRI and Gd-DTPA
49. CT and MRI of siderotic regenerating nodules in hepatic cirrhosis
50. Rapid MR imaging of the liver: Comparison of twelve techniques for single breath-hold whole volume acquisition
51. 3DFT-FISP MRI with gadopentetate dimeglumine in differential diagnosis of small liver tumors
52. Diagnostic approach to hepatic hemangiomas
53. Clinical safety of gadopentetate dimeglumine
54. Enhanced magnetic resonance imaging for tissue characterization of liver abnormalities with hepatobiliary contrast agents: An overview of preclinical animal experiments
55. Dynamic MRI of hepatic tumors using gadolinium-DTPA-Preliminary results
56. Enhancement characteristics of liver metastases, hepatocellular carcinomas, and hemangiomas with Gd-EOB-DTPA: Preliminary results with dynamic MR imaging
57. Magnetic resonance imaging of the solitary hepatic mass: Direct correlation with pathology and computed tomography
58. CT and MRI of diffuse liver disease
59. Abdominal MR imaging with a volumetric interpolated breath-hold examination
60. Correlation of perfusion abnormalities on CTAP and immediate postintravenous gadolinium-enhanced gradient echo MRI
61. Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies
62. Hepatic tumor imaging using iron oxide MRI: Comparison with computed tomography, clinical impact, and cost analysis
63. Evaluation of a 10-minute comprehensive MR imaging examination of the upper abdomen
64. Hepatic hemangiomas: A multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images
65. Liver metastases: Comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases
66. Liver lesion detection: Comparison between excitation-spoiling fat suppression and regular spin-echo at 1.5T
67. Biliary hamartomas: Solitary and multiple lesions shown on current MR techniques including gadolinium enhancement
68. Perilesional enhancement of hepatic metastases: Correlation between MR imaging and histopathologic findings-initial observations
69. HASTE MR imaging: Description of technique and preliminary results in the abdomen
70. Sequential use of ferumoxide particles and gadolinium chelate for the evaluation of focal liver lesions on MRI
71. Focal liver lesions: Comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement
72. Malignant liver lesions: Comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management
73. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2- weighted fat-suppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T
74. Malignant hepatic tumors: Changes on MRI after hepatic arterial chemoembolization-preliminary findings
75. Fast MR imaging of the liver: Quantitative comparison of techniques
76. Benign regenerative nodules with copper accumulation in a case of chronic Budd-Chiari syndrome: CT and MR findings
77. Deaths related to iodinated contrast media reported spontaneously to the U.S. Food and Drug Administration, 1978-1994: Effect of the availability of low-osmolality contrast media
78. Optimizing fast spin echo acquisitions for hepatic imaging in normal subjects
79. Focal masses in cirrhotic liver: CT and MR imaging features
80. MnDPDP for MR imaging of the liver. Results from the European phase III studies
81. Magnetic resonance imaging of the liver
82. Hepatic lesion detection: Comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis
83. MR imaging with IV superparamagnetic iron oxide: Efficacy in the detection of focal hepatic lesions
84. Fibrolamellar carcinoma of the liver
85. MR imaging during arterial portography for assessment of hepatocellular carcinoma: Comparison with CT during arterial portography
86. Helical (spiral) CT of the abdomen